Document is current
Any future updates will be listed below
-
Authors
Jimenez-Barragan, Marta https://orcid.org/0000-0001-8462-6630
del Pino Gutierrez, Amparo https://orcid.org/0000-0002-0385-1439
Garcia, Jorge Curto https://orcid.org/0000-0002-2854-9850
Monistrol-Ruano, Olga https://orcid.org/0000-0001-7605-8733
Coll-Navarro, Engracia https://orcid.org/0000-0001-8432-7075
Porta-Roda, Oriol
Falguera-Puig, Gemma https://orcid.org/0000-0002-6066-3960
-
Funding
Funding for this research was provided by:
PERIS Departament de Salut. Generalitat de Catalunya (Grant No. PERIS SLT006/17/249)
- License Information
-
More Information
Article History
Received: 11 June 2023
Accepted: 8 August 2023
First Online: 7 September 2023
Declarations
:
: The study was approved by the Drug Research Ethics Committee (CEIm; Comité de Ética de la Investigación con medicamentos, CEIm) from Mútua of Terrassa (Spain) (# approval: B1803). An informed consent will be obtained from all the participants that agree to participate.
: Not applicable.
: The authors declare no competing interests.
